Stephan D. Thomé

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent et al. · Journal of Clinical Oncology · 2004 · 1K citations

Medicine, Oncology, Chemotherapy +16

Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer

Charles L. Loprinzi, Stephan D. Thomé · Journal of Clinical Oncology · 2001 · 97 citations

Medicine, Oncology, Breast Oncology +14

Familial Myeloma

Henry T. Lynch, Kelly Ferrara, Bart Barlogie et al. · New England Journal of Medicine · 2008 · 87 citations · Full text

Medicine, Genetics, Oncology +15

Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group

Ronald S. Go, Nelson Leung, David Murray et al. · Mayo Clinic Proceedings · 2016 · 71 citations

Medicine, Hematology, Internal Medicine +12

Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone

Nelson Leung, Stephan D. Thomé, Angela Dispenzieri · Haematologica · 2018 · 54 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +9